Lipid profile analysis of type 2 diabetic patients in Bengaluru population, India

Shyamala K. Venkatesh, Sudheer K. M. V., Mohana Krishna T.


Background: Prevalence of Diabetes in India is 69.2 million, among which type 2 diabetes mellitus (T2DM), constitutes for 90% of all the diabetic populations. Previous studies have proved the association of T2DM, with increasing risk of cardiovascular diseases (CVDs) and the level of risk varies among males and females. The present study aims to analyze the lipid profile of T2DM patients and compare the lipid profile of T2DM males and females in Karnataka, Bengaluru population.

Methods: The study included 171 T2DM patients, 59 females and 112 males aged 21 years and above. Total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), very low density lipoprotein cholesterol (VLDL-C) and triglycerides (TG) concentrations values were analyzed for each group. Paired students t test was applied to identify the differences in lipid profile values of males and females with T2D.

Results: The mean value of TC, VLDL-C and LDL-C were higher in overall T2DM patients than the normal range and HDL-C was lower in T2DM patients. Comparison between males and females showed significantly higher LDL-C in females with T2DM than males. Other lipid parameters TC, TG and HDL-C did not show any significant differences between females and males with T2DM.

Conclusions: This study demonstrated the existence of dyslipidemia in T2DM population which is major risk factor for CVD. Greater LDL-C was observed in T2DM females compared to T2DM males suggests higher risk for CVD in females compared to males.


CVD, Type 2 diabetes mellitus, dyslipidemia

Full Text:



American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2009;32(Suppl 1):S62-S67.

Tripathi BK, Srivastava AK. Diabetes mellitus: complications and therapeutics. Med Sci Monit. 2006;12:RA130-147.

International Diabetes Federation Diabetes Atlas, Seventh Edition, 2015. Available at:

Maruthur NM. The growing prevalence of type 2 diabetes: increased incidence or improved survival? Curr Diab Rep. 2013;13:786-94.

Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Australas Med J. 2014;7(1):45-8.

Menke A, Rust KF, Fradkin J, Cheng YJ, Cowie CC. Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States. Ann Intern Med. 2014;161(5):328-35.

Oggioni C, Lara J, Wells JC, Soroka K, Siervo M. Shifts in population dietary patterns and physical inactivity as determinants of global trends in the prevalence of diabetes: an ecological analysis. Nutr Metab Cardiovasc Dis. 2014;24:1105-11.

Jan Mohamed HJ, Yap RW, Loy SL, Norris SA, Biesma R, Aagaard-Hansen J. Prevalence and determinants of overweight, obesity, and type 2 diabetes mellitus in adults in Malaysia. Asia Pac J Public Health. 2015;27:123-35.

Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291-7.

Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5:150-9.

Adiels M, Olofsson SO, Taskinen MR, Borén J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:1225-36.

Ozder A. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study. Lipids Health Dis. 2014;13:183.

Bardini G, Rotella CM, Giannini S. Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications. Rev Diabet Stud. 2012;9:82-93.

Song Q, Liu X, Wang A, Wang Y, Zhou Y, Zhou W, et al. Associations between non-traditional lipid measures and risk for type 2 diabetes mellitus in a Chinese community population: a cross-sectional study. Lipids Health Dis. 2016;15:70.

Gordon L, Ragoobirsingh D, Morrison E Y, Choo-Kang E, McGrowder D, Martorell E. Lipid profile of type 2 diabetic and hypertensive patients in the jamaican population. J Lab Physicians. 2010;2:25-30.

Singh G, Kumar AK. A Study of Lipid Profile in Type 2 Diabetic Punjabi Population. J Exercise Sci Physiotherapy. 2012;8:7-10.

Farid SM. Gender-related differences in lipid profile and atherogenic indices in patients with type 2 diabetes mellitus in Jeddah, Saudi Arabia. GJBB. 2017:430-8.

Laakso M. Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med. 2001;249(3):225-35.

Lorber D., Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2014;7:169-83.

Krauss RM, Siri PW. Dyslipidemia in type 2 diabetes. Med Clin N Am. 2004;88(4):897-909.

Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms. Diabetes Care. 2010;33(2):442-9.

Laws A, Hoen HM, Selby JV, Saad MF, Haffner SM, Howard BV. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status: relation to plasma triglyceride and apolipoprotein B concentrations: Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Arterioscler Thromb Vasc Biol. 1997;17(1):64-71.

Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation. 1990;82(2):495-506.